Bahram Valamehr, Chief Development Officer at FATE THERAPEUTICS INC (FATE), sold 49,600 shares at $89.68 ($4.4M) on 2021-06-14, disclosed to the SEC on 2021-06-16.
Open-market sale of $4.4M FATE by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.11 | 16,380 | $1.5M | 32.9% |
| 2 | $89.11 | 16,380 | $1.5M | 32.9% |
| 3 | $89.68 | 8,220 | $737K | 16.6% |
| 4 | $89.68 | 8,220 | $737K | 16.6% |
| 5 | $90.76 | 400 | $36K | 0.8% |
| Total | $89.31 avg | 49,600 |
| $4.4M |
| 100% |
| Filing → |
| FATE | SELL | 2026-01-12 | $6K | — | Filing → |
| FATE | SELL | 2025-08-05 | $15K | — | Filing → |
| FATE | SELL | 2025-01-13 | $13K | — | Filing → |